Flagship Pioneering launches biotech called Quotient Therapeutics
Quotient Therapeutics, which will have offices in Mass. and the United Kingdom, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.
Stay updated with breaking news from Flagship Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quotient Therapeutics, which will have offices in Mass. and the United Kingdom, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today unveiled Quotient Therapeutics, a company pioneering somatic genomics, the study...
Montai Health appoints Christian Antoni, M.D., Ph.D., as Chief Medical Officer....
/PRNewswire/ -- Every Cure, a non-profit organization committed to unlocking additional diseases and patients that can benefit from existing drugs, announced...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...